Everolimus (EVE) plus letrozole (LET) in patients (pts) with estrogen receptor-positive (ER plus ), human epidermal growth factor receptor 2-negative (HER2-) advanced breast cancer (ABC): Progression-free survival (PFS) subgroup analyses in BOLERO-4
Copy For Citation
Bachelot T., Royce M., Villanueva C., Melo Cruz F., Hegg R., Falkson C., ...More
42nd European-Society-for-Medical-Oncology Congress (ESMO), Madrid, Spain, 8 - 12 September 2017, vol.28
-
Publication Type:
Conference Paper / Summary Text
-
Volume:
28
-
City:
Madrid
-
Country:
Spain
-
Istanbul University Affiliated:
Yes